Grace will present a detailed discussion of the mechanisms of silica for solubility enhancement for BCS class II drugs. We will introduce effective methods of particle engineering of compendial silicon dioxide to create stable amorphous dispersions.Specific discussion will include:

• Case studies demonstrating technology efficacy
• Practical considerations for scale up and formulation development
• Benefits of this technology for transfer to clinical trials

Additionally, Grace will demonstrate the value creation of using compendial silicon dioxide for drug delivery.

Fred Monsuur
Global Excipients Commercial Development Manager
Grace

More Information & Registration